Oprozomib

Oprozomib
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T6041-1mg 1 mg

7 - 10 business days*

58.00€
TGM-T6041-5mg 5 mg

7 - 10 business days*

128.00€
TGM-T6041-1mL 1 ml

7 - 10 business days*

147.00€
TGM-T6041-10mg 10 mg

7 - 10 business days*

172.00€
TGM-T6041-25mg 25 mg

7 - 10 business days*

311.00€
TGM-T6041-50mg 50 mg

7 - 10 business days*

466.00€
TGM-T6041-100mg 100 mg

7 - 10 business days*

655.00€
 
Description: Oprozomib (PR-047) (ONX 0912) , an inhibitor for CT-L activity of 20S proteasome... more
Product information "Oprozomib"
Description: Oprozomib (PR-047) (ONX 0912) , an inhibitor for CT-L activity of 20S proteasome beta5(IC50=36 nM)/LMP7(IC50=82 nM), is orally bioavailable. Oprozomib also has potential antineoplastic activity. Target: Proteasome, Autophagy. Smiles: COC[C@H](NC(=O)[C@H](COC)NC(=O)c1cnc(C)s1)C(=O)N[C@@H](Cc1ccccc1)C(=O)[C@@]1(C)CO1. References: Zhou HJ, et al. J Med Chem, 2009, 52(9), 3028-3038.
Keywords: PR-047, ONX 0912
Supplier: TargetMol
Supplier-Nr: T6041

Properties

Application: Targets 20S proteasome subunit beta 5 [EC:3.4.25.1] (PSMB5)
MW: 532.61 D
Formula: C25H32N4O7S
Format: 32160405

Database Information

CAS : 935888-69-0| Matching products
KEGG ID : K02737 | Matching products

Handling & Safety

Storage: -20°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Oprozomib"
Write a review
or to review a product.
Viewed